Mon, November 20, 2023

Jessica Fye Initiated (BCRX) at Buy and Held Target at $10 on, Nov 20th, 2023

Jessica Fye of JP Morgan, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy and Held Target at $10 on, Nov 20th, 2023.

Jessica has made no other calls on BCRX in the last 4 months.



There are 4 other peers that have a rating on BCRX. Out of the 4 peers that are also analyzing BCRX, 0 agree with Jessica's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Jessica


  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $12 on, Monday, November 6th, 2023
  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $10 on, Monday, September 25th, 2023
  • Maury Raycroft of "Jefferies" Upgraded from Hold to Strong Buy and Held Target at $11 on, Friday, August 4th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Friday, August 4th, 2023